Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lennart Bunch

Showing results (51-60 of 70) with videos related to

Pageof 7
Sort By:
BMC Cancer|May 19, 2015
The glutamate transport inhibitor DL-Threo-β-Benzyloxyaspartic acid (DL-TBOA) differentially affects SN38- and oxaliplatin-induced death of drug-resistant colorectal cancer cellsElena Pedraz-Cuesta, Sandra Christensen, Anders A Jensen, et al.
Frontiers in Chemistry|December 5, 2022
Discovery of (<i>R</i>)-2-amino-3-triazolpropanoic acid derivatives as NMDA receptor glycine site agonists with GluN2 subunit-specific activityFabao Zhao, Georgios Mazis, Feng Yi, et al.
ACS Chemical Neuroscience|April 10, 2015
Binding mode of an α-amino acid-linked quinoxaline-2,3-dione analogue at glutamate receptor subtype GluK1Charles S Demmer, Charlotte Møller, Patricia M G E Brown, et al.
Journal of Medicinal Chemistry|June 27, 2008
Chemo-enzymatic synthesis of (2S,4R)-2-amino-4-(3-(2,2-diphenylethylamino)-3-oxopropyl)pentanedioic acid: a novel selective inhibitor of human excitatory amino acid transporter subtype 2Emanuelle Sagot, Anders A Jensen, Darryl S Pickering, et al.
Molecular Pharmacology|June 10, 2015
A Multifaceted GABAA Receptor Modulator: Functional Properties and Mechanism of Action of the Sedative-Hypnotic and Recreational Drug Methaqualone (Quaalude)Harriet Hammer, Benjamin M Bader, Corina Ehnert, et al.
Journal of Structural Biology|July 14, 2012
Pharmacological and structural characterization of conformationally restricted (S)-glutamate analogues at ionotropic glutamate receptorsLina Juknaitė, Raminta Venskutonytė, Zeinab Assaf, et al.
ACS Chemical Neuroscience|April 27, 2022
(<i>S</i>)-2-Mercaptohistidine: A First Selective Orthosteric GluK3 AntagonistChristian B M Poulie, Younes Larsen, Cindie Leteneur, et al.
European Journal of Pharmacology|February 27, 2004
Ibotenic acid and thioibotenic acid: a remarkable difference in activity at group III metabotropic glutamate receptorsMette B Hermit, Jeremy R Greenwood, Birgitte Nielsen, et al.
Journal of Medicinal Chemistry|September 23, 2010
Structure-activity relationship study of first selective inhibitor of excitatory amino acid transporter subtype 1: 2-Amino-4-(4-methoxyphenyl)-7-(naphthalen-1-yl)-5-oxo-5,6,7,8-tetrahydro-4H-chromene-3-carbonitrile (UCPH-101)Mette N Erichsen, Tri H V Huynh, Bjarke Abrahamsen, et al.
Journal of Medicinal Chemistry|August 12, 2024
Domoic Acid as a Lead for the Discovery of the First Selective Ligand for Kainate Receptor Subtype 5 (GluK5)Silke Buschbom-Helmke, Pengfei Wang, Anna Alcaide, et al.
Pageof 7

Showing results (51-60 of 70) with videos related to

Sort By:
Pageof 7
BMC Cancer|May 19, 2015
The glutamate transport inhibitor DL-Threo-β-Benzyloxyaspartic acid (DL-TBOA) differentially affects SN38- and oxaliplatin-induced death of drug-resistant colorectal cancer cellsElena Pedraz-Cuesta, Sandra Christensen, Anders A Jensen, et al.
Frontiers in Chemistry|December 5, 2022
Discovery of (<i>R</i>)-2-amino-3-triazolpropanoic acid derivatives as NMDA receptor glycine site agonists with GluN2 subunit-specific activityFabao Zhao, Georgios Mazis, Feng Yi, et al.
ACS Chemical Neuroscience|April 10, 2015
Binding mode of an α-amino acid-linked quinoxaline-2,3-dione analogue at glutamate receptor subtype GluK1Charles S Demmer, Charlotte Møller, Patricia M G E Brown, et al.
Journal of Medicinal Chemistry|June 27, 2008
Chemo-enzymatic synthesis of (2S,4R)-2-amino-4-(3-(2,2-diphenylethylamino)-3-oxopropyl)pentanedioic acid: a novel selective inhibitor of human excitatory amino acid transporter subtype 2Emanuelle Sagot, Anders A Jensen, Darryl S Pickering, et al.
Molecular Pharmacology|June 10, 2015
A Multifaceted GABAA Receptor Modulator: Functional Properties and Mechanism of Action of the Sedative-Hypnotic and Recreational Drug Methaqualone (Quaalude)Harriet Hammer, Benjamin M Bader, Corina Ehnert, et al.
Journal of Structural Biology|July 14, 2012
Pharmacological and structural characterization of conformationally restricted (S)-glutamate analogues at ionotropic glutamate receptorsLina Juknaitė, Raminta Venskutonytė, Zeinab Assaf, et al.
ACS Chemical Neuroscience|April 27, 2022
(<i>S</i>)-2-Mercaptohistidine: A First Selective Orthosteric GluK3 AntagonistChristian B M Poulie, Younes Larsen, Cindie Leteneur, et al.
European Journal of Pharmacology|February 27, 2004
Ibotenic acid and thioibotenic acid: a remarkable difference in activity at group III metabotropic glutamate receptorsMette B Hermit, Jeremy R Greenwood, Birgitte Nielsen, et al.
Journal of Medicinal Chemistry|September 23, 2010
Structure-activity relationship study of first selective inhibitor of excitatory amino acid transporter subtype 1: 2-Amino-4-(4-methoxyphenyl)-7-(naphthalen-1-yl)-5-oxo-5,6,7,8-tetrahydro-4H-chromene-3-carbonitrile (UCPH-101)Mette N Erichsen, Tri H V Huynh, Bjarke Abrahamsen, et al.
Journal of Medicinal Chemistry|August 12, 2024
Domoic Acid as a Lead for the Discovery of the First Selective Ligand for Kainate Receptor Subtype 5 (GluK5)Silke Buschbom-Helmke, Pengfei Wang, Anna Alcaide, et al.
Pageof 7